Background
Cavalli was born in Intragna, Switzerland.
- Photos
- Works
- Photos
- Works
Fabio Cavalli
Edit Profile
Career
Fabio Cavalli founded Mondobiotech in 2001. He registered 321 licences for the application of human peptides as medicaments for rare diseases. Fabio Cavalli brought the company to the Swiss Stock Exchange.
In 2011 he founded Genes Société Anonyme, a Swiss group operating in direct-to-consumer genetics.
Achievements
-
In 2005, Fabio Cavalli won the Swiss Life Sciences Prize, in 2006 the Ernst & Young Swiss Entrepreneur of the Year and in 2007 the A.T. Kearney Best Innovator Prize for its innovative product technology. In 2008 the World Economic Forum awarded him as Technology Pioneer for the creation of new technologies start up with significant impact on business and society. In 2008 he received the Swiss Innovation Award for the research in rare diseases, in 2010 the Patent Champion in the category of pharmaceutical industry and in 2011 the commitment from the Clinton Global Initiative to take action to Genes for the creation of a preventive model of healthcare that brings genetic testing and medicine to public.
-
Born
-
Nationality
Switzerland
Awards
-
Swiss Innovation Award; the World Economic Forum awarded In 2005, Fabio Cavalli won the Swiss Life Sciences Prize, in 2006 the Ernst & Young Swiss Entrepreneur of the Year and in 2007 the A.T. Kearney Best Innovator Prize for its innovative product technology. In 2008 the World Economic Forum awarded him as Technology Pioneer for the creation of new technologies start up with significant impact on business and society. In 2008 he received the Swiss Innovation Award for the research in rare diseases, in 2010 the Patent Champion in the category of pharmaceutical industry and in 2011 the commitment from the Clinton Global Initiative to take action to Genes for the creation of a preventive model of healthcare that brings genetic testing and medicine to public.Swiss Innovation Award; the World Economic Forum awarded In 2005, Fabio Cavalli won the Swiss Life Sciences Prize, in 2006 the Ernst & Young Swiss Entrepreneur of the Year and in 2007 the A.T. Kearney Best Innovator Prize for its innovative product technology. In 2008 the World Economic Forum awarded him as Technology Pioneer for the creation of new technologies start up with significant impact on business and society. In 2008 he received the Swiss Innovation Award for the research in rare diseases, in 2010 the Patent Champion in the category of pharmaceutical industry and in 2011 the commitment from the Clinton Global Initiative to take action to Genes for the creation of a preventive model of healthcare that brings genetic testing and medicine to public.